vs
安进（AMGN）与CARVANA CO.（CVNA）财务数据对比。点击上方公司名可切换其他公司
安进的季度营收约是CARVANA CO.的1.8倍（$9.9B vs $5.6B），CARVANA CO.净利率更高（15.3% vs 13.5%，领先1.8%），CARVANA CO.同比增速更快（58.0% vs 8.6%），安进自由现金流更多（$961.0M vs $379.0M），过去两年CARVANA CO.的营收复合增速更高（35.3% vs 15.1%）
安进是总部位于美国加利福尼亚州千橡市的跨国生物制药企业，公司名称取自最初的全称「应用分子遗传学」的缩写组合，按营收规模排名位列全球生物医药企业第18位，专注于研发、生产及商业化创新生物药物，为全球患者提供优质治疗选择。
Carvana Co.是总部位于美国亚利桑那州坦佩市的线上二手车零售企业，主打线上一站式购车服务，2021年成功入选《财富》500强榜单，是该榜单有史以来最年轻的上榜企业之一。
AMGN vs CVNA — 直观对比
营收规模更大
AMGN
是对方的1.8倍
$5.6B
营收增速更快
CVNA
高出49.4%
8.6%
净利率更高
CVNA
高出1.8%
13.5%
自由现金流更多
AMGN
多$582.0M
$379.0M
两年增速更快
CVNA
近两年复合增速
15.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.9B | $5.6B |
| 净利润 | $1.3B | $857.0M |
| 毛利率 | 69.8% | 18.8% |
| 营业利润率 | 27.6% | 7.6% |
| 净利率 | 13.5% | 15.3% |
| 营收同比 | 8.6% | 58.0% |
| 净利润同比 | 112.6% | 984.8% |
| 每股收益（稀释后） | $2.45 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMGNCVNA
| Q4 25 | $9.9B | $5.6B | ||
| Q3 25 | $9.6B | $5.6B | ||
| Q2 25 | $9.2B | $4.8B | ||
| Q1 25 | $8.1B | $4.2B | ||
| Q4 24 | $9.1B | $3.5B | ||
| Q3 24 | $8.5B | $3.7B | ||
| Q2 24 | $8.4B | $3.4B | ||
| Q1 24 | $7.4B | $3.1B |
净利润AMGNCVNA
| Q4 25 | $1.3B | $857.0M | ||
| Q3 25 | $3.2B | $151.0M | ||
| Q2 25 | $1.4B | $183.0M | ||
| Q1 25 | $1.7B | $216.0M | ||
| Q4 24 | $627.0M | $79.0M | ||
| Q3 24 | $2.8B | $85.0M | ||
| Q2 24 | $746.0M | $18.0M | ||
| Q1 24 | $-113.0M | $28.0M |
毛利率AMGNCVNA
| Q4 25 | 69.8% | 18.8% | ||
| Q3 25 | 67.8% | 20.3% | ||
| Q2 25 | 67.2% | 22.0% | ||
| Q1 25 | 63.6% | 22.0% | ||
| Q4 24 | 65.7% | 21.5% | ||
| Q3 24 | 61.1% | 22.1% | ||
| Q2 24 | 61.4% | 21.0% | ||
| Q1 24 | 57.0% | 19.3% |
营业利润率AMGNCVNA
| Q4 25 | 27.6% | 7.6% | ||
| Q3 25 | 26.4% | 9.8% | ||
| Q2 25 | 28.9% | 10.6% | ||
| Q1 25 | 14.5% | 9.3% | ||
| Q4 24 | 25.4% | 7.3% | ||
| Q3 24 | 24.1% | 9.2% | ||
| Q2 24 | 22.8% | 7.6% | ||
| Q1 24 | 13.3% | 4.4% |
净利率AMGNCVNA
| Q4 25 | 13.5% | 15.3% | ||
| Q3 25 | 33.7% | 2.7% | ||
| Q2 25 | 15.6% | 3.8% | ||
| Q1 25 | 21.2% | 5.1% | ||
| Q4 24 | 6.9% | 2.2% | ||
| Q3 24 | 33.3% | 2.3% | ||
| Q2 24 | 8.9% | 0.5% | ||
| Q1 24 | -1.5% | 0.9% |
每股收益（稀释后）AMGNCVNA
| Q4 25 | $2.45 | — | ||
| Q3 25 | $5.93 | — | ||
| Q2 25 | $2.65 | — | ||
| Q1 25 | $3.20 | — | ||
| Q4 24 | $1.17 | — | ||
| Q3 24 | $5.22 | — | ||
| Q2 24 | $1.38 | — | ||
| Q1 24 | $-0.21 | $0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.1B | $2.3B |
| 总债务越低越好 | $54.6B | $4.9B |
| 股东权益账面价值 | $8.7B | $3.4B |
| 总资产 | $90.6B | $13.2B |
| 负债/权益比越低杠杆越低 | 6.31× | 1.43× |
8季度趋势，按日历期对齐
现金及短期投资AMGNCVNA
| Q4 25 | $9.1B | $2.3B | ||
| Q3 25 | $9.4B | $2.1B | ||
| Q2 25 | $8.0B | $1.9B | ||
| Q1 25 | $8.8B | $1.9B | ||
| Q4 24 | $12.0B | $1.7B | ||
| Q3 24 | $9.0B | $871.0M | ||
| Q2 24 | $9.3B | $542.0M | ||
| Q1 24 | $9.7B | $252.0M |
总债务AMGNCVNA
| Q4 25 | $54.6B | $4.9B | ||
| Q3 25 | $54.6B | — | ||
| Q2 25 | $56.2B | — | ||
| Q1 25 | $57.4B | — | ||
| Q4 24 | $60.1B | $5.3B | ||
| Q3 24 | $60.4B | — | ||
| Q2 24 | $62.6B | — | ||
| Q1 24 | $64.0B | — |
股东权益AMGNCVNA
| Q4 25 | $8.7B | $3.4B | ||
| Q3 25 | $9.6B | $2.3B | ||
| Q2 25 | $7.4B | $1.7B | ||
| Q1 25 | $6.2B | $1.5B | ||
| Q4 24 | $5.9B | $1.3B | ||
| Q3 24 | $7.5B | $611.0M | ||
| Q2 24 | $5.9B | $526.0M | ||
| Q1 24 | $5.0B | $289.0M |
总资产AMGNCVNA
| Q4 25 | $90.6B | $13.2B | ||
| Q3 25 | $90.1B | $9.9B | ||
| Q2 25 | $87.9B | $9.4B | ||
| Q1 25 | $89.4B | $8.9B | ||
| Q4 24 | $91.8B | $8.5B | ||
| Q3 24 | $90.9B | $7.4B | ||
| Q2 24 | $90.9B | $7.2B | ||
| Q1 24 | $93.0B | $7.0B |
负债/权益比AMGNCVNA
| Q4 25 | 6.31× | 1.43× | ||
| Q3 25 | 5.67× | — | ||
| Q2 25 | 7.57× | — | ||
| Q1 25 | 9.24× | — | ||
| Q4 24 | 10.23× | 4.20× | ||
| Q3 24 | 8.02× | — | ||
| Q2 24 | 10.57× | — | ||
| Q1 24 | 12.75× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.6B | $430.0M |
| 自由现金流经营现金流 - 资本支出 | $961.0M | $379.0M |
| 自由现金流率自由现金流/营收 | 9.7% | 6.8% |
| 资本支出强度资本支出/营收 | 6.5% | 0.9% |
| 现金转化率经营现金流/净利润 | 1.20× | 0.50× |
| 过去12个月自由现金流最近4个季度 | $8.1B | $889.0M |
8季度趋势，按日历期对齐
经营现金流AMGNCVNA
| Q4 25 | $1.6B | $430.0M | ||
| Q3 25 | $4.7B | $345.0M | ||
| Q2 25 | $2.3B | $29.0M | ||
| Q1 25 | $1.4B | $232.0M | ||
| Q4 24 | $4.8B | $60.0M | ||
| Q3 24 | $3.6B | $403.0M | ||
| Q2 24 | $2.5B | $354.0M | ||
| Q1 24 | $689.0M | $101.0M |
自由现金流AMGNCVNA
| Q4 25 | $961.0M | $379.0M | ||
| Q3 25 | $4.2B | $307.0M | ||
| Q2 25 | $1.9B | $-2.0M | ||
| Q1 25 | $980.0M | $205.0M | ||
| Q4 24 | $4.4B | $36.0M | ||
| Q3 24 | $3.3B | $376.0M | ||
| Q2 24 | $2.2B | $332.0M | ||
| Q1 24 | $459.0M | $83.0M |
自由现金流率AMGNCVNA
| Q4 25 | 9.7% | 6.8% | ||
| Q3 25 | 44.4% | 5.4% | ||
| Q2 25 | 20.8% | -0.0% | ||
| Q1 25 | 12.0% | 4.8% | ||
| Q4 24 | 48.4% | 1.0% | ||
| Q3 24 | 39.0% | 10.3% | ||
| Q2 24 | 26.5% | 9.7% | ||
| Q1 24 | 6.2% | 2.7% |
资本支出强度AMGNCVNA
| Q4 25 | 6.5% | 0.9% | ||
| Q3 25 | 4.6% | 0.7% | ||
| Q2 25 | 4.0% | 0.6% | ||
| Q1 25 | 5.0% | 0.6% | ||
| Q4 24 | 4.1% | 0.7% | ||
| Q3 24 | 3.0% | 0.7% | ||
| Q2 24 | 2.8% | 0.6% | ||
| Q1 24 | 3.1% | 0.6% |
现金转化率AMGNCVNA
| Q4 25 | 1.20× | 0.50× | ||
| Q3 25 | 1.46× | 2.28× | ||
| Q2 25 | 1.59× | 0.16× | ||
| Q1 25 | 0.80× | 1.07× | ||
| Q4 24 | 7.61× | 0.76× | ||
| Q3 24 | 1.26× | 4.74× | ||
| Q2 24 | 3.30× | 19.67× | ||
| Q1 24 | — | 3.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMGN
| Products | $9.4B | 95% |
| Xgeva | $291.0M | 3% |
| Vectibix | $163.0M | 2% |
| Aranesp | $115.0M | 1% |
CVNA
| Used Vehicle Sales | $4.2B | 74% |
| Wholesale Sales And Revenues | $988.0M | 18% |
| Other | $459.0M | 8% |
